Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
People of color now have less access to prescription opioid painkillers than white patients, an unintended consequence of ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...
As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?
For example, opioid prescriptions for cancer or hospice patients have declined at a comparable rate to that of the general population, even though those patients have a legitimate need for the ...
The amount of women who were diagnosed with a substance use disorder in Ohio when they delivered their babies has increased over the years, but are the resources in our communities available to help ...
If you had a machine that was manufacturing bullets in the commonwealth and you sold them, you couldn’t do that legally," a ...
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
President Trump made improving Americans’ health a centerpiece of his 2024 campaign. Perhaps no issue has devastated our public health more over the last 25 years than the opioid crisis.
Those opioids were later revealed to be highly addictive ... are inaccessible to patients despite their effectiveness. As an example, he said that chiropractic care is the most cost-effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results